NCT07078474

Brief Summary

This study aims to compare the effects of two different methods of applying hyaluronic acid (HA) on skin parameters in healthy individuals. HA is a widely used ingredient in skincare products due to its hydrating properties. However, it is unclear whether applying HA to dry or pre-moistened skin provides better results in terms of skin hydration and texture. In this non-invasive, interventional trial, 23 healthy volunteers aged 18 to 50 will be randomly assigned to two groups. One group will apply HA to dry skin, while the other will apply HA to moistened skin. Skin parameters will be measured before and after the intervention to assess hydration, transepidermal water loss, and overall skin condition. The aim is to determine the optimal method of HA application that maximizes its effectiveness in improving skin quality. Participants may benefit from improved skin hydration and increased awareness of the best application method for their skin type. No significant risks are expected from participation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 18, 2025

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 9, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 11, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 22, 2025

Completed
Last Updated

July 22, 2025

Status Verified

June 1, 2025

Enrollment Period

21 days

First QC Date

July 11, 2025

Last Update Submit

July 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in skin hydration level

    Skin hydration will be measured at four time points using a corneometer or comparable non-invasive skin analysis device. Measurements will be taken before the intervention (baseline) and at the end of each week to assess cumulative and comparative effects of hyaluronic acid application.

    Baseline, Week 1, Week 2, Week 3

Study Arms (2)

Dry Skin Application

EXPERIMENTAL

Participants in this group applied hyaluronic acid topically to clean, dry skin. The aim was to evaluate hydration and skin parameter changes following this method of application.

Other: Topical Hyaluronic Acid

Moist Skin Application

EXPERIMENTAL

Participants in this group applied hyaluronic acid topically to pre-moistened skin. The goal was to assess whether applying the product to damp skin enhances its hydrating effect.

Other: Topical Hyaluronic Acid

Interventions

Hyaluronic acid was applied topically to the facial skin of healthy participants once daily for a period of 3 weeks. Two application methods were used: on dry skin and on pre-moistened skin. Skin measurements were performed at baseline and after each week of intervention (Week 1, Week 2, and Week 3) to assess hydration and other skin parameters.

Dry Skin ApplicationMoist Skin Application

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy individuals aged 18 to 50 years
  • Willingness to apply the product daily for 3 weeks
  • Ability to attend all scheduled skin assessments (baseline + weekly)
  • Provided written informed consent

You may not qualify if:

  • Known allergy or sensitivity to hyaluronic acid or any component of the product
  • Active skin diseases or dermatological conditions in the facial area
  • Use of systemic or topical corticosteroids or retinoids within 4 weeks prior to study
  • Pregnancy or breastfeeding
  • Participation in another clinical trial within the past 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Split School of Medicine

Split, Split-Dalmatia County, 21000, Croatia

Location

MeSH Terms

Interventions

Hyaluronic Acid

Intervention Hierarchy (Ancestors)

GlycosaminoglycansPolysaccharidesCarbohydrates

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2025

First Posted

July 22, 2025

Study Start

June 18, 2025

Primary Completion

July 9, 2025

Study Completion

July 9, 2025

Last Updated

July 22, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations